Search Results for "Minor Blood Group Incompatibility"
Matching Channels
When a patient has had a serious accident and lost a lot of blood, or has a blood disorder, their own blood can be replaced with blood that has been donated by other people. Because of the differe...
Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug
Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...
Pulmonary arterial hypertension group 1
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals,...
Matching News
Owens & Minor wraps up $163M buyout of Movianto
Medical device distributor Owens & Minor announced it has finalized its purchase of the Movianto Group from Celesio for about -More-
Owens & Minor purchases Movianto Group
Owens & Minor has purchased an European healthcare third-party logistics (3PL) business, Movianto Group, from Celesio, for approximately €130m ($163m) in cash.
Researchers have uncovered the gene at the root of a human blood group that has remained a mystery for the past 60 years. They showed that a genetic deletion on this gene is responsible for the lack o...
TEXT-S&P: Owens & Minor ratings unchanged by Movianto deal
July 24 - Standard & Poor's Ratings Services said today that its ratings on Richmond, Va-based medical products distributor Owens & Minor Inc. (OMI; BBB/Stable/--) are not affected by the company's bi...
Owens & Minor, Inc. (NYSE: OMI) will participate in the R. W. Baird 2012 Healthcare Conference – Thursday, September 6, 2012 at 12:50 p.m. EDT in New York. The Owens & M...
Owens & Minor Announces 9% Increase in the Dividend for First Quarter 2013
Owens & Minor, Inc. (NYSE: OMI) announced that its board of directors has approved the payment of the first quarter 2013 cash dividend in the amount of $0.24 per share, a 9% i...
Owens & Minor Announces Second Quarter 2013 Cash Dividend of $0.24 per Share
Owens & Minor, Inc. (NYSE:OMI) today announced that its board of directors has approved the payment of the second-quarter 2013 cash dividend in the amount of $0.24 per share....
Owens & Minor, Inc. (NYSE:OMI) will participate in the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Tuesday, January 8, 2013, at 2:00 p.m. Pa...
Matching PubMed Articles
Minor anomalies in children with hematological malignancies.
BACKGROUND: Despite the presence of reports on correlation between major congenital defects and cancer, very few studies have investigated the frequency of minor anomalies in childhood malignancy. The...
Background/Aims: Recent studies have reported the potentials of endoscopic papillary large balloon dilatation (EPLBD) with minor endoscopic sphincterotomy (EST) for the complete removal of common bile...
Significant association between ABO blood group and pancreatic cancer.
AIM: To evaluate whether the ABO blood group is related to pancreatic cancer risk in the general population of the United States. METHODS: Using the University of Pittsburgh's clinical pancreatic canc...
Determination of the complete mitochondrial DNA sequence of Octopus minor.
In this study, we have determined the complete nucleotide sequence of the mitochondrial genome of Octopus minor. It is 15,974 nucleotide pairs and encodes 13 proteins, two ribosomal RNAs and 22 tRNAs...
Evolutionary and functional diversity of the Pseudomonas type IVa pilin island.
Summary In Pseudomonas aeruginosa, most proteins involved in type IVa pilus (T4aP) biogenesis are highly conserved except for the major pilin PilA and the minor pilins involved in pilus assembly. Here...
